Ultime notizie per ContraFect Corp (OTC:CFRX) Azioni

ContraFect

ContraFect Corp

CONTRAFECT CORP by ContraFect Corporation

<h3>Gainers</h3>
<ul>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) shares climbed 83.5% to $0.4169 after reporting first-quarter results.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) shares climbed 59.5% to $1.18 after the company announced it received a non-binding proposal from founders Chris Kemp and Adam London offering to acquire all of the outstanding common stock of the company not currently owned by Kemp and London.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) gained 50% to $4.22 following third-quarter results.</li>
<li>Virgin Galactic Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spce#NYSE">SPCE</a>) surged 27.5% to $1.99 after the company reported better-than-expected third-quarter financial results.</li>
<li>The Honest Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hnst#NASDAQ">HNST</a>) gained 23% to $1.4780 following upbeat quarterly results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) rose 22.7% to $26.70 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>Infinera Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) gained 22.6% to $4.06 following preliminary third-quarter results..</li>
<li>JanOne Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jan#NASDAQ">JAN</a>) shares climbed 22.4% to $0.3936 as gaining over 7% on Wednesday.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 22% to $10.43 on the heels of the company&#39;s quarterly results.</li>
<li>SomaLogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slgc#NASDAQ">SLGC</a>) rose 21.3% to $2.4750 following strong quarterly results.</li>
<li>PubMatic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pubm#NASDAQ">PUBM</a>) shares climbed 20.4% to $14.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>LiveRamp Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ramp#NYSE">RAMP</a>) rose 19.4% to $35.83 after the company posted upbeat second-quarter results and issued strong sales forecast.</li>
<li>OncoCyte Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) gained 18.5% to $2.55 following third-quarter results.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) shares rose 17.8% to $8.28 after Valor Economico Reported that Abu Dhabi&#39;s Adnoc Made a new offer to acquire a stake in the Brazilian petrochemical producer. Braskem also reported results for the third quarter.</li>
<li>Calumet Specialty Products Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmt#NASDAQ">CLMT</a>) surged 16.3% to $15.12 following third-quarter results.</li>
<li>Seritage Growth Properties (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srg#NYSE">SRG</a>) gained 16.3% to $8.65 following third-quarter results.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 16.1% to $11.94.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) gained 15.4% to $11.57 after the company reported better-than-expected third-quarter financial results.</li>
<li>Jackson Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jxn#NYSE">JXN</a>) climbed 14.4% to $44.55 following strong earnings.</li>
<li>Bakkt Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkkt#NYSE">BKKT</a>) shares rose 14.2% to $0.7326 after declining 29% on Wednesday.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) gained 13.2% to $0.3225.</li>
<li>Carrols Restaurant Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tast#NASDAQ">TAST</a>) gained 10.8% to $6.90 after the company reported better-than-expected third-quarter financial results.</li>
<li>Globavend Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvh#NASDAQ">GVH</a>) shares climbed 10.4% to $2.8501. Globavend Holdings recently announced pricing of $6 million initial public offering of 1.5 million shares of common stock at a price of $4 per share.</li>
<li>The Walt Disney Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) rose 6.2% to $89.74 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Tapestry, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpr#NYSE">TPR</a>) gained 6.2% to $29.17 following upbeat earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) tumbled 75.3% to $0.9501 following third-quarter results. Enviva named Glenn Nunziata as interim Chief Executive Officer in addition to his CFO role.</li>
<li>ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) fell 69.4% to $0.0711.</li>
<li>Atara Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atra#NASDAQ">ATRA</a>) dipped 67% to $0.40 after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint of confirmed disability improvement (CDI) by expanded disability status scale (EDSS) at 12 months compared to placebo.</li>
<li>Ikena Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikna#NASDAQ">IKNA</a>) declined 61% to $1.5768 following weak sales.</li>
<li>WideOpenWest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wow#NYSE">WOW</a>) shares fell 59.3% to $3.0050 following third-quarter results. Keybanc downgraded WideOpenWest from Overweight to Sector Weight.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) shares declined 55% to $6.16 after the company reported downbeat sales results for the third quarter.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) shares dipped 53.9% to $0.42 after the company announced a public offering of 4,444,444 ordinary shares at a price of $0.45 per share.</li>
<li>Acutus Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) fell 46.6% to $0.2500 following quarterly results.</li>
<li>Assertio Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asrt#NASDAQ">ASRT</a>) fell 46.2% to $1.14 after the company reported worse-than-expected third-quarter financial results.</li>
<li>James River Group Holdings, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jrvr#NASDAQ">JRVR</a>) dipped 35.8% to $8.44. James River Group recently reported worse-than-expected third-quarter revenue results.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) shares fell 32.5% to $2.0907 after the company reported weak quarterly sales.</li>
<li>Fossil Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fosl#NASDAQ">FOSL</a>) fell 31.1% to $1.1915 following third-quarter results.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) declined 29% to $0.9771. The company recently announced Family Medicine Specialists selected the company&#39;s epigenetic-genetic tests to identify patients at risk for coronary heart disease.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) fell 26.8% to $13.17 after the company reported worse-than-expected third-quarter financial results.</li>
<li>ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) declined 25.5% to $13.16 following third-quarter financial results.</li>
<li>Inspired Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inse#NASDAQ">INSE</a>) fell 25.3% to $7.77. Inspired said it requires additional time to complete financial statements for the third quarter and restate certain previously issued financial statements.</li>
<li>Cyngn Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NYSE">CYN</a>) fell 24.7% to $0.1994 following weak sales.</li>
<li>Traeger, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cook#NYSE">COOK</a>) declined 22.2% to $2.2950 following quarterly earnings.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) fell 22% to $0.5352 following quarterly results.</li>
<li>FREYR Battery (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frey#NYSE">FREY</a>) declined 21.3% to $2.6350 after reporting quarterly earnings.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) fell 16% to $4.5597 following third-quarter results.</li>
<li>Royalty Management Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmco#NASDAQ">RMCO</a>) dipped 16% to $6.79.</li>
<li>Topgolf Callaway Brands Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modg#NYSE">MODG</a>) fell 15.9% to $10.47 after the company reported mixed third-quarter financial results.</li>
<li>Cipher Mining Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cifr#NASDAQ">CIFR</a>) declined 15.4% to $3.02. Bitfury Group announced sale of 10 million shares of Cipher Mining common stock at a price of $2.95 per share and lock-up agreement for remaining holding.</li>
<li>BILL Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) shares fell 14.8% to $52.94. Bill Holdings is in advanced talks to acquire Melio Payments, Bloomberg reported, citing people with knowledge of the matter.</li>
<li>Phibro Animal Health Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pahc#NASDAQ">PAHC</a>) dipped 14% to $10.35 following weak results.</li>
<li>Genpact Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/g#NYSE">G</a>) dropped 13.8% to $29.93 following weak sales.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) fell 13.8% to $8.69 after the company reported quarterly financial results and announced a $350 million at-the-market offering.</li>
<li>Luminar Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lazr#NASDAQ">LAZR</a>) shares declined 13.2% to $3.1938 after the company reported mixed third-quarter financial results.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) declined 12.4% to $13.44 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) shares fell 12% to $1.3116 following a wider-than-expected quarterly loss.</li>
<li>Instacart (Maplebear Inc.) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cart#NASDAQ">CART</a>) fell 11.1% to $24.21 following third-quarter results.</li>
<li>HeartCore Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htcr#NASDAQ">HTCR</a>) shares fell 11% to $0.4724 after declining 7% on Wednesday.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) declined 8.9% to $12.24 following weak results.</li>
<li>Myriad Genetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mygn#NASDAQ">MYGN</a>) shares declined 6.4% to $16.73 after announcing pricing of upsized offering of common stock.</li>
<li>Arm Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arm#NASDAQ">ARM</a>) fell 6.2% to $51.02 after the company reported second-quarter financial results and issued guidance.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) shares declined 5% to $7.92 after posting weak quarterly sales.</li>
<li>CCC Intelligent Solutions Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccs#NASDAQ">CCCS</a>) shares declined 4.1% to $11.21. CCC Intelligent Solutions priced secondary offering of 65 million shares at $10.50 per share.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/11/35701311/ethereum-surpasses-1-900-following-jobless-claims-data-huobi-token-emerges-as-top-gainer"> Ethereum Surpasses $1,900 Following Jobless Claims Data; Huobi Token Emerges As Top Gainer</a>

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AFIB

AFRM

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ASLE

ASRT

ASTR

ATRA

BILL

Bakkt Holdings, Inc. Class A Common Stock

BKKT

CART

CCCS

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CDLX

CFRX

CIFR

CLMT

COOK

DNUT

FOSL

FREY

GDRX

HNST

HTCR

IKNA

Intelligent Bio Solutions Inc. - Common Stock

INBS

INFN

INSE

JRVR

LAZR

MARA

MODG

MYGN

NVTA

PAHC

PUBM

RAMP

RIOT

RMCO

RVNC

SLGC

SNES

SPCE

TAST

Tempest Therapeutics, Inc. - Common Stock

TPST

WLDS

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Offerings

Contrafect Filed For Offering Of $15M Of Shares Of Common Stock, Class E Warrants And Class F Warrants

<h3>Gainers</h3>
<ul>
<li>Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) shares moved upwards by 11.7% to $2.95 during Friday's after-market session. Today's trading volume for this security ended up closing at 1.4 million shares, which is 55.1 percent of its average volume over the last 100 days. The company's market cap stands at $313.8 million. </li>
<li>Aligos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) stock increased by 11.56% to $0.69. The market value of their outstanding shares is at $30.0 million. </li>
<li>ContraFect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFRX#NASDAQ">CFRX</a>) shares moved upwards by 11.36% to $0.3. The market value of their outstanding shares is at $1.6 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares rose 9.61% to $1.65. The market value of their outstanding shares is at $101.6 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock moved upwards by 8.1% to $0.8. The company's market cap stands at $9.3 million. </li>
<li>Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) shares increased by 7.99% to $4.05. The company's market cap stands at $91.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Connect Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) stock declined by 10.0% to $1.24 during Friday's after-market session. The market value of their outstanding shares is at $68.3 million. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) stock decreased by 8.0% to $0.94. At the close, SeaStar Medical Holding's trading volume reached 8.5 million shares. This is 64.8% of its average volume over the last 100 days. The company's market cap stands at $18.2 million. </li>
<li>Allarity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares fell 6.93% to $0.56. The company's market cap stands at $2.3 million. </li>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) stock decreased by 6.41% to $1.17. The company's market cap stands at $6.7 million. </li>
<li>Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) stock fell 5.34% to $1.42. This security traded at a volume of 152.4K shares come close, making up 49.1% of its average volume over the last 100 days. The company's market cap stands at $69.0 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock fell 5.33% to $1.6. This security traded at a volume of 210.3K shares come close, making up 12.1% of its average volume over the last 100 days. The company's market cap stands at $21.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALGS

ALLR

CHRS

CNTB

LIFW

LIPO

PROK

RVPH

SGHT

VRPX

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>CVRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) stock moved upwards by 48.0% to $19.0 during Thursday's after-market session. The company's market cap stands at $394.3 million. As per the news, the Q3 earnings report came out today. </li>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) stock increased by 32.57% to $1.05. At the close, SeaStar Medical Holding's trading volume reached 5.3 million shares. This is 40.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.4 million. </li>
<li>Eargo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAR#NASDAQ">EAR</a>) shares moved upwards by 24.37% to $1.99. At the close, Eargo's trading volume reached 505.1K shares. This is 2469.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $41.2 million. </li>
<li>DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) stock moved upwards by 14.69% to $93.01. DexCom's trading volume hit 598.8K shares by close, accounting for 13.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $36.0 billion. The company's, Q3 earnings came out today. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock rose 13.08% to $2.68. The company's market cap stands at $1.5 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock increased by 12.96% to $0.12. Trading volume for this security closed at 14.1 million, accounting for 605.5% of its average full-day volume over the last 100 days. The company's market cap stands at $27.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock decreased by 31.5% to $0.28 during Thursday's after-market session. Trading volume for this security closed at 15.4 million, accounting for 333.3% of its average full-day volume over the last 100 days. The company's market cap stands at $3.4 million. </li>
<li>PTC Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTCT#NASDAQ">PTCT</a>) stock declined by 15.75% to $20.18. PTC Therapeutics's trading volume hit 80.0K shares by close, accounting for 6.8% of its average volume over the last 100 days. The company's market cap stands at $1.5 billion. The company's, Q3 earnings came out today. </li>
<li>ContraFect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFRX#NASDAQ">CFRX</a>) stock declined by 15.25% to $0.26. The company's market cap stands at $1.4 million. </li>
<li>Bio-Rad Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIO#NYSE">BIO</a>) shares decreased by 10.82% to $260.0. The market value of their outstanding shares is at $7.5 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) shares decreased by 7.31% to $9.34. The company's market cap stands at $812.6 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares declined by 7.13% to $0.3. This security traded at a volume of 90.2K shares come close, making up 4.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVRX

DAWN

DXCM

PCSA

PTCT

RNAZ

SXTC

TCRT

12 Health Care Stocks Moving In Thursday's After-Market Session

ContraFect Corp Selling Securityholder May Offer And Sell Up To 7M Shares In Aggregate Of Common Stock

<a href="https://patentcenter.uspto.gov/applications/16629916/ifw/docs" title="https://patentcenter.uspto.gov/applications/16629916/ifw/docs">https://patentcenter.uspto.gov/applications/16629916/ifw/docs</a>
<figure class="image"><img src="https://pbs.twimg.com/media/F9NpXXLagAAAYk2?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/F9NpXWebgAAxga6?format=jpg&amp;name=900x900" alt="Image" /></figure>

Biotech

General

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

Gainers
INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares climbed 187.4% to $0.25 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England&rsquo;s first community-based heart and lung screening hub.
Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) shares climbed 125% to $0.3279 after the company reached an agreement with Stonepeak to become a private company.
Textainer Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgh#NYSE">TGH</a>) shares gained 44.5% to $49.33 after the company agreed to be acquired by Stonepeak for $7.4 billion.
Twin Ridge Capital Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trca#NYSE">TRCA</a>) climbed 17.7% to $8.11.
Bright Green Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgxx#NASDAQ">BGXX</a>) rose 17.6% to $0.4156.
Navios Maritime Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nm#NYSE">NM</a>) gained 17.2% to $2.21. N Logistics Holdings announced plans to acquire all outstanding shares of common stock of Navios Maritime Holdings not already owned by NLHC for $2.28 per share.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) gained 16.2% to $0.5576.
TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 16% to $1.2775
FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) jumped 15.8% to $0.3323.
NOVONIX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NASDAQ">NVX</a>) climbed 15.4% to $2.10
The Alkaline Water Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wter#NASDAQ">WTER</a>) shares rose 14.6% to $0.2290 after falling 14% on Friday.
Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) surged 13.6% to $0.3580.
Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) rose 13% to $1.7850.
EngageSmart, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esmt#NYSE">ESMT</a>) gained 12.1% to $22.65 after the company announced it would be acquired by Vista Equity Partners for $23 per share.
Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) rose 11.2% to $5.36.
Abacus Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abl#NASDAQ">ABL</a>) climbed 8.4% to $6.81.
Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) shares gained 7.6% to $9.55 following a spike in Bitcoin.
Hut 8 Mining Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hut#NASDAQ">HUT</a>) gained 7% to $1.9889 amid a rise in Bitcoin.
Losers
Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) fell 43.2% to $15.85 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
Li-Cycle Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/licy#NYSE">LICY</a>) shares fell 42.4% to $1.3087 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..
Apollomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplm#NASDAQ">APLM</a>) dipped 38% to $1.08 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.
XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 36.6% to $0.4050 after jumping more than 100% on Friday.
Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) fell 36% to $0.3597. Aclarion signed a LOI with ATEC to advance commercialization of Nociscan.
Great Ajax Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ajx#NYSE">AJX</a>) declined 33% to $4.26 after the company and Ellington Financial announced the mutual termination of their merger agreement.
Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 27.5% to $3.60.
Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares fell 27.3% to $0.8001 after reporting financial results for the quarter ended June 30, 2023.
WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) fell 26.3% to $0.56 after gaining over 38% on Friday.
Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) declined 23.7% to $0.38.
Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) fell 23% to $1.86.
MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 21.1% to $1.1350.
Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) declined 20.9% to $6.66. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (&ge;50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.
Ryvyl Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvyl#NASDAQ">RVYL</a>) fell 20% to $2.31.
C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) declined 18.2% to $1.53.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 17.4% to $0.1643. GameSquare Holdings and FaZe Holdings recently entered into a definitive agreement pursuant to which GameSquare will acquire FaZe Clan in an arm&#39;s length all-stock transaction.
Erayak Power Solution Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/raya#NASDAQ">RAYA</a>) fell 16.4% to $0.7101.
Biocept, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bioc#NASDAQ">BIOC</a>) fell 16.3% to $0.4730.
Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) shares fell 15.8% to $5.80 after the company. Harpoon announced a private placement of PIPE equity of up to $150 million. The company disclosed announced updated data from a trial evaluating its cancer drug.
Falcon&#39;s Beyond Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbyd#NASDAQ">FBYD</a>) dipped 15.6% to $14.57.
FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) fell 12.7% to $58.52 after the company updated its third-quarter and FY23 outlook.
VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 12.3% to $4.72. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) shares fell 11.9% to $0.3172 in pre-market trading after declining 10% on Friday. The company recently reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.
Catalyst Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) fell 11.7% to $0.4414 in pre-market trading after climbing around 25% on Friday.
Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) fell 10.5% to $0.2417 in pre-market trading after gaining 10% on Friday.
Golden Sun Education Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsun#NASDAQ">GSUN</a>) shares fell 10.1% to $0.4691 after declining 5% on Friday.
Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) declined 8.9% to $68.87 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.
World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 8% to $102.50 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.
NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) declined 7.4% to $6.50. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35374121/bitcoin-tops-this-key-level-fantom-emerges-as-top-gainer"> Bitcoin Tops This Key Level; Fantom Emerges As Top Gainer</a>

ACON

AGFY

AMAM

APLM

BGXX

BIOC

BRSH

CBIO

CCCC

DBGI

ESMT

FAZE

FBYD

FTCH

GSUN

HARP

INVO

LICY

LMDX

MOTS

NAMS

Nuveen California Dividend Advantage Municipal Fund 2

OKTA

RAYA

RVMD

RVYL

SPEC

TRCA

TRKA

WLGS

WRLD

WTER

WULF

XRTX

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers
LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England&rsquo;s first community-based heart and lung screening hub.
Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) shares rose 56.6% to $0.2285 in pre-market trading after the company reached an agreement with Stonepeak to become a private company.
Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) rose 47.5% to $2.08 in pre-market trading. Next.e.GO Mobile and Athena Consumer Acquisition announced the completion of their previously announced business combination.
Textainer Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgh#NYSE">TGH</a>) shares gained 42.6% to $48.69 in pre-market trading after the company agreed to be acquired by Stonepeak for $7.4 billion.
Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) shares climbed 37.2% to $9.44 in pre-market trading after the company disclosed Updated interim tolerability and response data from Phase 1/2 clinical trial of T Cell engager HPN328 at ESMO Congress 2023.
The Alkaline Water Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wter#NASDAQ">WTER</a>) shares rose 35% to $0.2699 in pre-market trading after falling 14% on Friday.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) gained 29.7% to $0.6226 in pre-market trading.
LM Funding America, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmfa#NASDAQ">LMFA</a>) shares jumped 18.8% to $0.5468 in pre-market trading after jumping 12% on Friday.
Roivant Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roiv#NASDAQ">ROIV</a>) rose 15.2% to $11.13 in pre-market trading. Roche agreed to acquire Telavant, including rights to novel TL1A-directed antibody (RVT-3101), from Roivant for $7.1 billion.
Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bets#NASDAQ">BETS</a>) shares rose 12.2% to $0.5490 in pre-market trading.
Losers
XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) dipped 21.7% to $0.50 in pre-market trading after jumping more than 100% on Friday.
Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares fell 20.9% to $0.87 in pre-market trading after reporting financial results for the quarter ended June 30, 2023.
Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares fell 18.8% to $0.3042 in pre-market trading after gaining 14% on Friday.
TD Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glg#NASDAQ">GLG</a>) shares fell 18.8% to $0.0723 in pre-market trading after dipping 13% on Friday.
WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) fell 18.3% to $0.62 in pre-market after gaining over 38% on Friday.
Golden Sun Education Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsun#NASDAQ">GSUN</a>) shares fell 13.6% to $0.4510 in pre-market trading after declining 5% on Friday.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 12.1% to $0.1750 in pre-market trading. GameSquare Holdings and FaZe Holdings recently entered into a definitive agreement pursuant to which GameSquare will acquire FaZe Clan in an arm&#39;s length all-stock transaction.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) shares fell 11.9% to $0.3172 in pre-market trading after declining 10% on Friday. The company recently reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.
Catalyst Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) fell 11.7% to $0.4414 in pre-market trading after climbing around 25% on Friday.
Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) fell 10.5% to $0.2417 in pre-market trading after gaining 10% on Friday.
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/10/35366898/fear-among-us-investors-is-growing-heres-why"> Fear Among US Investors Is Growing: Here&#39;s Why</a>

Pre-Market Outlook

BETS

EGOX

LMFA

ROIV

Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Better Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTTX#NASDAQ">BTTX</a>) stock rose 56.7% to $0.49 during Monday's pre-market session. The market value of their outstanding shares is at $19.9 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock increased by 31.21% to $0.42. The company's market cap stands at $2.4 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares moved upwards by 28.47% to $0.62. The company's market cap stands at $15.1 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock rose 22.74% to $0.53. The company's market cap stands at $1.9 million. </li>
<li>ContraFect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFRX#NASDAQ">CFRX</a>) stock moved upwards by 22.67% to $0.7. The market value of their outstanding shares is at $3.8 million. </li>
<li>Ambrx Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAM#NASDAQ">AMAM</a>) stock rose 21.35% to $17.05. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aldeyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALDX#NASDAQ">ALDX</a>) shares fell 73.5% to $1.44 during Monday's pre-market session. The company's market cap stands at $84.3 million. </li>
<li>Biocept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOC#NASDAQ">BIOC</a>) shares decreased by 55.89% to $0.45. The market value of their outstanding shares is at $1.1 million. </li>
<li>Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) stock declined by 45.82% to $1.23. The market value of their outstanding shares is at $77.3 million. </li>
<li>Leap Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) shares decreased by 19.08% to $1.23. The company's market cap stands at $31.4 million. </li>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares decreased by 17.2% to $0.62. The company's market cap stands at $7.1 million. </li>
<li>Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) shares declined by 16.11% to $0.62. The market value of their outstanding shares is at $36.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALDX

BPTH

BTTX

LPTX

OMER

RDHL

STRM

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers
LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey&#39;s presence on store shelves.
Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) shares rose 84.4% to $0.8853 in pre-market trading after jumping 45% on Friday.
MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) shares gained 62.8% to $0.7766 in pre-market trading after gaining more than 10% on Friday.
PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) shares climbed 47.4% to $6.87 in pre-market trading. On Friday, Amphenol Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aph#NYSE">APH</a>) inked a deal to acquire PCTEL for around$139.7 million.
RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) shares rose 43.8% to $0.46 in pre-market trading after falling 14% on Friday.
Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) rose 37.7% to $0.8810 in pre-market trading after declining 37% on Friday.
ESSA Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/epix#NASDAQ">EPIX</a>) gained 32.1% to $3.62 in pre-market trading.
Almacenes &Eacute;xito S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/exto#NYSE">EXTO</a>) shares rose 31.6% to $6.61 in pre-market trading.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) shares jumped 30% to $0.7398 in pre-market trading after the company reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.
Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) rose 24.9% to $17.55 in pre-market trading.
Losers
Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) dipped 24.8% to $4.47 in pre-market trading after jumping 140% on Friday.
Shift Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sft#NASDAQ">SFT</a>) shares fell 24.1% to $0.1199 in pre-market trading. Maruthi J. D. Venkata reported a 4.8% stake in Shift Technologies as of Oct 12, 2023 versus an 11.5% stake reported as of March 14, 2023.
ParaZero Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/przo#NASDAQ">PRZO</a>) shares fell 19.1% to $2.67 in pre-market trading, after jumping 55% on Friday.
Bio-Path Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpth#NASDAQ">BPTH</a>) shares fell 19.1% to $0.6060 in pre-market trading after jumping around 111% on Friday.
AquaBounty Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqb#NASDAQ">AQB</a>) fell 15.8% to $3.45 in pre-market trading.
Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) fell 14.5% to $0.20 in pre-market trading. Versus Systems reported pricing of $3.0 million public offering.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 12.5% to $0.2039 in pre-market trading after jumping around 25% on Friday.
UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) shares fell 10.7% to $0.2810 in pre-market trading, after gaining over 7% on Friday.
Manchester United plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/manu#NYSE">MANU</a>) shares fell 10.6% to $17.85 in pre-market trading.
BioNTech SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntx#NASDAQ">BNTX</a>) fell 6% to $97.35 in pre-market after the company&#39;s partner, Pfizer, cut its COVID-19 vaccine and therapy sales outlook.
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/10/35258152/why-the-fear-level-among-us-investors-is-growing"> Why The Fear Level Among US Investors Is Growing</a>

BNTX

EPIX

EXTO

MANU

PCTI

PRZO

SASI

SECO

YGMZ

Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

ContraFect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study

Gainers
SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares jumped 89% to $0.6805, after falling 13% on Monday.
SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares climbed 87.1% to $3.18 after the company announced it secured a majority stake in True Gold Consortium.
PowerFleet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pwfl#NASDAQ">PWFL</a>) gained 42% to $2.80. Powerfleet and MiX Telematics entered into a definitive agreement to form one of the largest mobile asset Internet of Things Software-as-a-Service providers in the world.
SaverOne 2014 Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svre#NASDAQ">SVRE</a>) rose 31.1% to $0.7010.
Intrusion Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intz#NASDAQ">INTZ</a>) gained 30.4% to $0.4565. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers.
Startek, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/srt#NYSE">SRT</a>) gained 29.1% to $4.21 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash.
CISO Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) shares climbed 29.1% to $0.18. CISO Global said its Argo Edge Cloud Security Platform has been independently valued at $49 million.
Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) climbed 27.1% to $1.8050, after gaining more than 11% on Monday.
PGT Innovations, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pgti#NYSE">PGTI</a>) surged 21.8% to $31.92.
NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) gained 20.7% to $1.4506 after the company disclosed third-quarter preliminary results and a reorganization designed to accelerate its path to profitability.
Erasca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eras#NASDAQ">ERAS</a>) rose 20.6% to $2.6550.
Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) climbed 19% to $0.2209.
MDxHealth SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxh#NASDAQ">MDXH</a>) gained 18.5% to $2.82. MDxHealth reported preliminary revenues of $19.3 million for the third quarter, representing an increase of 73% year over year.
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares surged 15.5% to $1.1550. Lexicon Pharmaceuticals said INPEFA received preferred formulary status with Express Scripts for Medicare patients.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) rose 13.4% to $0.5108, after surging more than 12% on Monday.
Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) gained 13% to $0.7733. Canopy Growth received EU GMP certification from RP Tuebingen, Regional Health Inspectorate of Baden-Wuerttemberg for its cannabis cultivation facility in Kincardine, Ontario.
Coherent Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cohr#NYSE">COHR</a>) climbed 12% to $34.73 after the company announced Denso Corporation and Mitsubishi Electric Corporation have agreed to invest an aggregate $1 billion in its silicon carbide business.
Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 8% to $2.6250.
Rackspace Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NASDAQ">RXT</a>) gained 8.1% to $1.67.
Hyatt Hotels Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/h#NYSE">H</a>) gained 5.6% to $110.33 after it was announced the company will join the S&amp;P MidCap 400.
Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) shares rose 5.6% to $1.68 after the company announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with progressive multiple sclerosis (PMS).
Unity Software Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) shares surged 4.1% to $30.92 after the company announced a CEO transition. Unity announced that John Riccitiello will retire as chairman, president and CEO, effective immediately.
Losers
Akero Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akro#NASDAQ">AKRO</a>) shares fell 63.9% to $17.52 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin.
Athersys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athx#NASDAQ">ATHX</a>) dipped 46% to $0.1620 after the company reported interim analysis results of MASTERS-2 clinical study with multistem in ischemic stroke and signed a Memorandum of Understanding for global ARDS license with Healios.
89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) fell 37.7% to $9.68.
HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) fell 32% to $0.4547.
Gamer Pakistan Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpak#NASDAQ">GPAK</a>) declined 27% to $1.63. Gamer Pakistan priced its IPO at $4 per share.
ParaZero Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/przo#NASDAQ">PRZO</a>) shares declined 23.7% to $2.06. ParaZero Technologies shares jumped 133% on Monday after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems..
Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) dipped 22.1% to $23.38 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.
Molekule Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mkul#NASDAQ">MKUL</a>) shares fell 21.7% to $0.1009 after gaining around 5% on Monday.
Maris-Tech Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtek#NASDAQ">MTEK</a>) fell 21.6% to $1.09.
Maison Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mss#NASDAQ">MSS</a>) fell 20% to $5.20, after dipping 11% on Monday.
Fitell Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftel#NASDAQ">FTEL</a>) fell 15.3% to $1.60.
Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) declined 14% to $0.1290
Phoenix Motor Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pev#NASDAQ">PEV</a>) fell 11.3% to $1.40, after surging 58% on Monday. Phoenix Motor said its EdisonFuture subsidiary launched new Proton Exchange Membrane (PEM) solutions for green hydrogen products and production.
Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) declined 11.3% to $1.2501.
John Wiley &amp; Sons, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wly#NYSE">WLY</a>) declined 10.4% to $31.02 after reporting a CEO transition.
Falcon&#39;s Beyond Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbyd#NASDAQ">FBYD</a>) fell 9.6% to $13.50.
Lipella Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lipo#NASDAQ">LIPO</a>) fell 9.5% to $0.95.
RVL Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvlp#NASDAQ">RVLP</a>) shares fell 9.2% to $0.1732, after jumping over 50% on Monday.
Groupon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grpn#NASDAQ">GRPN</a>) fell 9% to $13.83.
Borqs Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brqs#NASDAQ">BRQS</a>) fell 8.6% to $0.9649 after declining more than 13% on Monday. Borqs Technologies recently announced a 1-for-12 reverse stock split.
VIA optronics AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/viao#NYSE">VIAO</a>) fell 8.5% to $1.18.
PagerDuty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pd#NYSE">PD</a>) declined 3.7% to $21.03 after the company announced a proposed private placement of $350 million of convertible senior notes.
Now Read This: <a href="https://www.benzinga.com/news/23/10/35157619/top-3-tech-and-telecom-stocks-you-may-want-to-dump-in-october"> Top 3 Tech And Telecom Stocks You May Want To Dump In October </a>

AKRO

ATHX

Borqs Technologies, Inc. - Ordinary Shares

BRQS

CISO

COHR

ERAS

ETNB

FTEL

GPAK

GRPN

HUBC

IMUX

INTZ

LXRX

MDXH

MKUL

Merrill Lynch & Strategic Return Notes for Select 10 Index

MTEK

NSTG

OPEN

PGTI

PWFL

RVLP

SPCB

SVRE

VIAO

VTYX

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers
SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.
Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) shares gained 13.2% to $1.80 in pre-market trading after the company disclosed positive interim data from Phase 2 CALLIPER trial of vidofludimus calcium in progressive multiple sclerosis.
Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) shares rose 21.1% to $0.2785 in pre-market trading, after falling 8% on Monday.
Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) rose 41.1% to $2.05&nbsp;in pre-market trading, after gaining more than 11% on Monday.
SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares climbed 18.2% to $2.01 in pre-market trading, after jumping 18% on Monday. Domaine Des Massifs and SMX recently formed a strategic collaboration to revolutionize traceability.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) rose 16.8% to $0.5277 in pre-market trading, after surging more than 12% on Monday.
ParaZero Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/przo#NASDAQ">PRZO</a>) shares jumped 13.8% to $3.07 in pre-market trading. ParaZero Technologies shares jumped 133% on Monday after the company announced an Australian regulator approved the first commercial drone flights in populated areas and near people using the ParaZero safety systems.
Sonendo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sonx#NYSE">SONX</a>) gained 11.2% to $0.4172 in pre-market trading, after gaining 23% on Monday. Sonendo recently revealed a Receipt of notice of non-compliance with the NYSE Trading Share Price Listing Rule.
Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares surged 11% to $1.11 in pre-market trading. Lexicon Pharmaceuticals said INPEFA received preferred formulary status with Express Scripts for Medicare patients.
ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) shares rose 9% to $0.58 in pre-market trading. ReTo Eco-Solutions recently reported a $15 million registered direct offering and $10 million concurrent private placement.
Losers
Borqs Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brqs#NASDAQ">BRQS</a>) fell 50.8% to $0.52 in pre-market trading after declining more than 13% on Monday. Borqs Technologies recently announced a 1-for-12 reverse stock split.
Phoenix Motor Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pev#NASDAQ">PEV</a>) fell 14.6% to $1.35 in pre-market trading, after surging 58% on Monday. Phoenix Motor said its EdisonFuture subsidiary launched new Proton Exchange Membrane (PEM) solutions for green hydrogen products and production.
Atreca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcel#NASDAQ">BCEL</a>) shares fell 12.8% to $0.2011 in pre-market trading.
RVL Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvlp#NASDAQ">RVLP</a>) shares fell 11.4% to $0.1689 in pre-market trading, after jumping over 50% on Monday.
Molekule Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mkul#NASDAQ">MKUL</a>) shares fell 10.2% to $0.1158 in pre-market trading after gaining around 5% on Monday.
Windtree Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wint#NASDAQ">WINT</a>) fell 9.9% to $1.09 in pre-market trading.
Applied UV, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auvi#NASDAQ">AUVI</a>) shares fell 9.8% to $0.3121 in pre-market trading. The company recently announced its new product, the Airocide Pro+ air purification system for food preservation, which will be on display at the Global Produce &amp; Floral Show.
Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) fell 9.1% to $0.2272 in pre-market trading. Vascular Biogenics, during August, posted a narrower loss for the second quarter.
Maison Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mss#NASDAQ">MSS</a>) fell 9.2% to $5.90 in pre-market, after dipping 11% on Monday.
Future FinTech Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) shares fell 8.7% to $0.95 in pre-market trading.
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/10/35145201/walgreens-likely-to-report-lower-q4-earnings-heres-a-look-at-recent-price-target-changes-by-the-mos"> Walgreens Likely To Report Lower Q4 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>

AUVI

BCEL

FTFT

RETO

SONX

VBLT

WINT

Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) stock increased by 57.3% to $3.02 during Monday's regular session. The current volume of 4.6 million shares is 2194.2% of Acurx Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $39.2 million. </li>
<li>Turnstone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSBX#NASDAQ">TSBX</a>) stock increased by 32.05% to $3.09. As of 13:31 EST, Turnstone Biologics's stock is trading at a volume of 163.1K, which is 147.8% of its average full-day volume over the last 100 days. The company's market cap stands at $70.5 million. </li>
<li>Jin Medical International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares increased by 29.26% to $17.8. Trading volume for this security as of 13:31 EST is 106.4K, which is 57.0% of its average full-day volume over the last 100 days. The company's market cap stands at $137.9 million. </li>
<li>ContraFect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFRX#NASDAQ">CFRX</a>) stock rose 24.74% to $0.5. As of 13:31 EST, this security is trading at a volume of 764.2K shares, making up 1414.1% of its average full-day volume over the last 100 days. The company's market cap stands at $2.7 million. </li>
<li>Freeline Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRLN#NASDAQ">FRLN</a>) stock rose 16.84% to $3.33. The current volume of 89.5K shares is 17.9% of Freeline Therapeutics's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $14.5 million. </li>
<li>RVL Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVLP#NASDAQ">RVLP</a>) shares moved upwards by 15.98% to $0.15. As of 13:31 EST, this security is trading at a volume of 42.9 million shares, making up 353.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) shares decreased by 21.1% to $0.42 during Monday's regular session. Trading volume for SeaStar Medical Holding's stock is 6.0 million as of 13:31 EST. This is 92.9% of its average full-day volume over the last 100 days. The company's market cap stands at $8.2 million. </li>
<li>Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) stock declined by 18.17% to $0.36. Trading volume for Addex Therapeutics's stock is 117.1K as of 13:31 EST. This is 178.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.7 million. </li>
<li>Etao International Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETAO#NASDAQ">ETAO</a>) stock declined by 16.6% to $0.18. As of 13:31 EST, Etao International Co's stock is trading at a volume of 475.0K, which is 146.3% of its average full-day volume over the last 100 days. The company's market cap stands at $18.7 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares fell 15.06% to $1.58. As of 13:31 EST, Longeveron's stock is trading at a volume of 469.0K, which is 161.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.4 million. </li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) shares fell 13.67% to $0.95. As of 13:31 EST, Vaccinex's stock is trading at a volume of 2.0 million, which is 439.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.6 million. </li>
<li>Tango Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) shares declined by 13.1% to $9.89. Tango Therapeutics's stock is trading at a volume of 1.4 million shares as of 13:31 EST. This is 75.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

ContraFect Corp

Notizie

Ultime notizie per ContraFect Corp (OTC:CFRX) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO